343 related articles for article (PubMed ID: 17906401)
1. [Pathophysiology in rickets/osteomalacia].
Takeuchi Y
Clin Calcium; 2007 Oct; 17(10):1508-13. PubMed ID: 17906401
[TBL] [Abstract][Full Text] [Related]
2. FGF23 and Bone and Mineral Metabolism.
Fukumoto S
Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of hypophosphatemia.
Ito N; Hidaka N; Kato H
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101851. PubMed ID: 38087658
[TBL] [Abstract][Full Text] [Related]
4. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
Fukumoto S
Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
[TBL] [Abstract][Full Text] [Related]
5. Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.
Feng JQ; Clinkenbeard EL; Yuan B; White KE; Drezner MK
Bone; 2013 Jun; 54(2):213-21. PubMed ID: 23403405
[TBL] [Abstract][Full Text] [Related]
6. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
Fukumoto S
Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
[TBL] [Abstract][Full Text] [Related]
7. [FGF23-related hypophosphatemic rickets/osteomalacia].
Ito N; Fukumoto S
Clin Calcium; 2007 Oct; 17(10):1514-20. PubMed ID: 17906402
[TBL] [Abstract][Full Text] [Related]
8. [Rickets/Osteomalacia. Action of FGF23.].
Inoue D
Clin Calcium; 2018; 28(10):1335-1342. PubMed ID: 30269115
[TBL] [Abstract][Full Text] [Related]
9. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23 and its receptors.
Yu X; White KE
Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
[TBL] [Abstract][Full Text] [Related]
11. [Disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
[TBL] [Abstract][Full Text] [Related]
12. A Practical Approach to Vitamin D Deficiency and Rickets.
Allgrove J; Shaw NJ
Endocr Dev; 2015; 28():119-133. PubMed ID: 26138839
[TBL] [Abstract][Full Text] [Related]
13. Skeletal mineralization: mechanisms and diseases.
Michigami T
Ann Pediatr Endocrinol Metab; 2019 Dec; 24(4):213-219. PubMed ID: 31905439
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of assay system for fibroblast growth factor (FGF)-23 and pathophysiological roles of FGF-23 in the development of hypophosphatemic diseases].
Fukumoto S; Nakahara K
Rinsho Byori; 2004 Jan; 52(1):51-4. PubMed ID: 14968560
[TBL] [Abstract][Full Text] [Related]
15. [FGF23 and bone metabolism].
Ito N; Fukumoto S
Clin Calcium; 2005 Jul; 15(7):43-8. PubMed ID: 15995295
[TBL] [Abstract][Full Text] [Related]
16. Hypophosphatemic rickets and osteomalacia.
de Menezes Filho H; de Castro LC; Damiani D
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):802-13. PubMed ID: 17117305
[TBL] [Abstract][Full Text] [Related]
17. Osteomalacia.
Francis RM; Selby PL
Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):145-63. PubMed ID: 9222490
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and bone disease.
Christodoulou S; Goula T; Ververidis A; Drosos G
Biomed Res Int; 2013; 2013():396541. PubMed ID: 23509720
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency or resistance and hypophosphatemia.
Sarathi V; Dhananjaya MS; Karlekar M; Lila AR
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101876. PubMed ID: 38365463
[TBL] [Abstract][Full Text] [Related]
20. Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23.
Ito N; Kubota T; Kitanaka S; Fujiwara I; Adachi M; Takeuchi Y; Yamagami H; Kimura T; Shinoda T; Minagawa M; Okazaki R; Ozono K; Seino Y; Fukumoto S
J Bone Miner Metab; 2021 Nov; 39(6):1066-1075. PubMed ID: 34255195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
